Introduction: Patients with differentiated thyroid cancer (DTC) are usually managed with total thyroidectomy and subsequent radioiodine ablation of the remnant thyroid tissue. Since these patients become athyrotic, L-throxine (L-T4) therapy is required for life, in order to replace the thyroid hormones and also to suppress the endogenous thyroid stimulating hormone (TSH) which may have a growth-promoting effect on any residual thyroid cancer cells. The approximate dose required to achieve this suppression is about 2 g/kg.
Pharm.D. Internship Research Day is an annual forum to highlight research projects of final-year undergraduate Pharm.D. students.
The primary goals of Research Day are to showcase the various types of research in Clinical Pharmacy department, share our mutual interests, and develop intra- and interdepartmental collaborations.
تحرير ضمن المعلومات الشخصية